©The Author(s) 2022.
World J Orthop. Jan 18, 2022; 13(1): 11-35
Published online Jan 18, 2022. doi: 10.5312/wjo.v13.i1.11
Published online Jan 18, 2022. doi: 10.5312/wjo.v13.i1.11
Table 4 Clinical presentation and management of local anesthetic systemic toxicity
| Local anesthetic systemic toxicity (LAST) |
| Clinical presentation of LAST |
| 1 Dizziness, drowsiness, tinnitus, perioral numbness |
| 2 Muscle twitching and tremors |
| 3 Seizures |
| 4 CNS depression, coma |
| 5 Hypertension, tachycardia |
| 6 Myocardial depression, ventricular arrhythmias, conduction delays |
| 7 EKG changes: Prolonged PR, QRS; T-wave changes |
| 8 Cardiovascular collapse |
| Management of LAST |
| 1 Call for help |
| 2 Call for LAST rescue kit |
| 3 Consider early lipid emulsion administration |
| (1) Under 70 kg: Bolus 1.5 mL/kg over 2-3 min, Infuse 0.25 mL/kg/min. Repeat bolus or double the infusion rate if the patient remains unstable |
| (2) Over 70 kg: Bolus approximately 100 mL over 2-3 min, infuse approximately 250 mL over 15-20 min. Repeat bolus or double the infusion rate if the patient remains unstable |
| (3) If the patient is stable, continue lipid emulsion ≥ 15 min after hemodynamic stability. Maximum lipid dose: 12 mL/kg |
| 4 Seizure |
| (1) Airway management |
| (2) Benzodiazepine |
| (3) Consider low dose propofol |
| 5 Arrhythmia or cardiovascular Instability |
| (1) Epinephrine: Administered at lower dose than ACLS dosing, start with ≤ 1 mcg/kg |
| (2) Avoid local anesthetics, beta-blockers, vasopressin, calcium channel blockers |
| (3) Consider alerting cardiopulmonary bypass team |
| 6 Close monitoring |
| Once stable, continue close monitoring: 2 h after seizure, 4-6 h after cardiovascular instability, and as clinically appropriate after cardiac arrest |
- Citation: Kamel I, Ahmed MF, Sethi A. Regional anesthesia for orthopedic procedures: What orthopedic surgeons need to know. World J Orthop 2022; 13(1): 11-35
- URL: https://www.wjgnet.com/2218-5836/full/v13/i1/11.htm
- DOI: https://dx.doi.org/10.5312/wjo.v13.i1.11